Skip to main content
Clinical Trials/NCT05805150
NCT05805150CompletedNot Applicable

Performance Evaluation of Different Daily Disposable Contact Lenses in Habitual Lens Wearers Who Report Frequent Use of Digital Devices

CooperVision, Inc.4 sites in 1 country69 target enrollmentStarted: March 13, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
69
Locations
4
Primary Endpoint
Lens Handling on Removal

Study Overview

Brief Summary

The goal of this study is to compare the performance of two daily disposable silicone hydrogel lenses.

Detailed Description

This study is prospective, bilateral eye, double masked, randomized, 1 week cross-over, daily wear design involving in two different daily disposable lens types. Each lens type will be worn for approximately one week.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Is between 18 and 35 years of age (inclusively) and has full legal capacity to volunteer;
  • •Has read and signed an information consent letter;
  • •Self-reports having a full eye examination in the previous two years;
  • •Self-reports spending on most days at least 6 hours cumulative (not necessarily in one single stretch) using digital devices such as a computer, laptop, tablet, e-reader, smartphone;
  • •Anticipates being able to wear the study lenses for at least 8 hours a day, 7 days a week;
  • •Is willing and able to follow instructions and maintain the appointment schedule;
  • •Habitually wears soft contact lenses, for the past 3 months minimum;
  • •No more than 1/3 of participants should be habitual wearer of MyDay or MyDay Energys
  • •No more than 1/3 of participants should be habitual wearer of ACUVUE® OASYS MAX 1-Day or ACUVUE® OASYS 1-Day.
  • •Has refractive astigmatism no higher than -0.75DC in each eye;
  • •Can be fit and achieve binocular distance vision of at least 20/30 Snellen (Available lens parameters are sphere -1.00 to -6.00D, 0.25D steps).

Exclusion Criteria

  • •Is participating in any concurrent clinical or research study;
  • •Has any known active ocular disease and/or infection that contraindicates contact lens wear;
  • •Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  • •Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable;
  • •Has known sensitivity to the diagnostic sodium fluorescein used in the study;
  • •Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
  • •Has undergone refractive error surgery or intraocular surgery.

Arms & Interventions

Control Lens, Then Test Lens

Experimental

Participants will wear control lenses for one week and then crossover to test lenses for one week.

Intervention: Test Lens (senofilcon A) (Device)

Test Lens, Then Control Lens

Experimental

Participants will wear test lenses for one week and then crossover to control lenses for one week.

Intervention: Control Lens (stenfilcon A) (Device)

Test Lens, Then Control Lens

Experimental

Participants will wear test lenses for one week and then crossover to control lenses for one week.

Intervention: Test Lens (senofilcon A) (Device)

Control Lens, Then Test Lens

Experimental

Participants will wear control lenses for one week and then crossover to test lenses for one week.

Intervention: Control Lens (stenfilcon A) (Device)

Outcomes

Primary Outcomes

Lens Handling on Removal

Time Frame: Collected once on day 6 at the end of wear

Ease of lens removal on a 0-100 scale (0= very difficult, 100= very easy)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (4)

Loading locations...

Similar Trials